Posoleucel in Kidney Transplant Recipients with BK Viremia: Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial

Affiliations

• ¹ Division of Renal Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
• ² Division of Renal Medicine, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, Massachusetts.
• ³ Inova Transplant Center, Falls Church, Virginia.
• ⁴ Rhode Island Hospital, Providence, Rhode Island.
• ⁵ University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
• ⁶ University of Cincinnati, Cincinnati, Ohio.
• ⁷ Northwestern University, Chicago, Illinois.
• ⁸ Northwell Health, New Hyde Park, New York.
• ⁹ University of California Davis, Sacramento, California.
• ¹⁰ Washington University School of Medicine at St. Louis, St. Louis, Missouri.
• ¹¹ University of Michigan, Ann Arbor, Michigan.
• ¹² University of Kansas, Kansas City, Kansas.
• ¹³ UPMC Pinnacle Health, Harrisburg, Pennsylvania.
• ¹⁴ Tulane University, New Orleans, Louisiana.
• ¹⁵ Loyola Medicine, Burr Ridge, Illinois.
• ¹⁶ Cleveland Clinic, Cleveland, Ohio.
• ¹⁷ Duke University, Durham, North Carolina.
• ¹⁸ Indiana University School of Medicine, Indianapolis, Indiana.
• ¹⁹ Virginia Commonwealth University, Richmond, Virginia.
• ²⁰ New York University Langone Health, New York, New York.
• ²¹ University of Minnesota, Minneapolis, Minnesota.
• ²² University of California, San Francisco, California.
• ²³ SHARP Kidney and Pancreas Transplant Center, San Diego, California.
• ²⁴ Weill Cornell Medical College, New York, New York.
• ²⁵ Piedmont Transplant Institute, Atlanta, Georgia.
• ²⁶ University of Nebraska Medical Center, Omaha, Nebraska.
• ²⁷ AlloVir, Inc., Waltham, Massachusetts.
• ²⁸ Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, Texas.
• ²⁹ Immune Evaluation Laboratory, Baylor College of Medicine, Houston, Texas.
• ³⁰ University of Texas Southwestern Medical Center, Dallas, Texas.